A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene

Gynecological Endocrinology

Volumn 10, Issue 1, 1996, Pages 33-39

  Dusterberg B ^a   Ellman, H ^a   Muller U ^a   Rowe, E ^a   Muhe B ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Cycle control; Ethinylestradiol; Gestodene; Oral contraceptives

Indexed keywords

ETHINYLESTRADIOL PLUS GESTODENE; LOW DOSE ORAL CONTRACEPTIVE;

ACNE; ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BREAKTHROUGH BLEEDING; CHLOASMA; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; FEMALE SEXUAL DYSFUNCTION; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LONG TERM CARE; MASTALGIA; MENSTRUAL CYCLE; METRORRHAGIA; MIGRAINE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PREGNANCY RATE; PRIORITY JOURNAL; THROMBOPHLEBITIS; VARICOSIS; VERTIGO; VOMITING;

ADOLESCENT; ADULT; AMENORRHEA; CONTRACEPTIVES, ORAL, COMBINED; DYSMENORRHEA; ETHINYL ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; NORPREGNENES; PATIENT COMPLIANCE; PREGNANCY; UTERINE HEMORRHAGE;

EID: 0029971678     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609041268     Document Type: Article

References (13)

1. Thorogood, M. and Vessey, M. P. (1990). Trends in use of oral contraceptives in Britain. Br. J. Fam. Plann., 16, 41-53
2. Scowen, E. E. (1969). Oral contraceptives containing oestrogen. Br. Med. J., 2, 744
3. RCGP Oral Contraception Study. (1977). Mortality among oral contraceptive users. Lancet, 2, 727-30
4. Vessey, M. P., McPherson, K. and Johnson, B. (1977). Mortality among women participating in the Oxford/Family Planning Association Contraceptive Study. Lancet, 2, 731-4
5. Upton, G. V. (1983). The phasic approach of oral contraception: the triphasic concept and its clinical applications. Int. J. Fertil., 28, 121-40
6. Fotherby, K. (1989). Oral contraceptives and lipids. Br. Med. J., 298, 1049-50
7. Fitzgerald, C., Feichtinger, W., Spona, J., Elstein, M., Lüdicke, F., Müller, U. and Williams, C. (1994). A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation. Adv. Contracept., 10, 5-18
8. Lähteenmäki, P., Moorrees, M., De Prest, J., Elomaa, K., Rolland, R. and Brosens, I. (1995). Extension of the pill-free period by three days in oral contraceptive users. Adv. Contracept., 11, 37-8
9. Hoppe, G. (1988). Gestodene, an innovative progestogen. Contraception, 37, 493-501
10. Rabe, T., Runnebaum, B., Kohlmeier, M., Harenberg, J. and Weicker, H. (1987). Clinical and metabolic effects of gestodene and levonorgestrel. Int. J. Fertil. 32, 29-44
11. Andrade, R. P. (1989). A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinylestradiol). Int. J. Fertil., 34 (Suppl.), 22-30
12. Data on file, Schering AG
13. Fotherby, K. (1992). Clinical experience and pharmacological effects of an oral contraceptive containing 20 μg oestrogen. Contraception, 46, 477-88